Molecular Structure BPC157 Peptide Class: Cytoprotective angiogenic peptide Peptide Length: 15 amino acids Key Features: Angiogenesis, fibroblast recruitment, inflammation modulation Form: Lyophilized powder, researchgrade TB500 (Thymosin Beta4 Fragment) Peptide Class: Actinbinding repair peptide Peptide Length: 17 amino acids (fragment) Key Features: Cytoskeletal modulation, cellmigration signaling Form: Lyophilized powder, researchgrade KPV (LysProVal) Peptide Class: Antiinflammatory melanocortinderived tripeptide Peptide Length: 3 amino acids Key Features: Cytokine modulation, epithelial repair, inflammation control Form: Lyophilized powder, researchgrade Each component is supplied independently and combined for multiaxis vascularrepair research
Benefits of 5-Amino-1MQ Boosts metabolism without using stimulants Targets stubborn fat and aids in body recomposition Increases cellular energy and NAD+ production Improves insulin sensitivity and blood sugar balance Supports healthy aging and long-term vitality Who Its Good For Clients stuck at a weight loss plateau Those with metabolic challenges (e.g., PCOS, prediabetes) Individuals experiencing brain fog, low energy, or burnout Clients using peptides or GLP-1s seeking added support Anyone interested in longevity and graceful aging Who Should Avoid It Pregnant or breastfeeding individuals Clients with active cancer or undergoing treatment Those with unmanaged liver, kidney, or autoimmune conditions Dosing Guidelines Standard dose: 50100 mg daily, taken orally Typically used in 48 week cycles Often paired with clean nutrition, hydration, and lifestyle support All supplement plans are reviewed during your medical consultation Available now at Luxura Medspa as part of your personalized longevity and weight management protocol
KLOW adds a fourth peptide, KPV, for enhanced anti-inflammatory action
Understanding BPC 157 and TB 500 BPC 157 is a peptide derived from a protein found in the stomachs gastric juice
The FDA committee was tasked with reviewing data that supports using these peptides to treat a variety of specific conditions, such as BPC-157 for treating ulcerative colitis, an inflammatory bowel disease
The peptide promoted Schwann cell proliferation, enhanced axonal regrowth, and improved nerve conduction velocity recovery
